# Samplix funding rounds and investors

As of 1 Nov 2026, Samplix has raised $27.8M across 1 verified round on record (amounts in other currencies converted to USD); latest: €25M first close round led by WLanholding GmbH (“WLan”), announced 27 Oct 2026.

Samplix provides advanced single cell analysis and isolation technology to reveal cell function at single-cell resolution.

Website: https://samplix.com/  
Headquarters: Copenhagen, Denmark  
Page: https://fireround.dev/companies/samplix

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-10-27 | First close | €25M | WLanholding GmbH (“WLan”) | none named | [bio-itworld.com](https://www.bio-itworld.com/pressreleases/2026/10/27/samplix-secures-backing-to-accelerate-xdrop-s-commercial-expansion-in-antibody-discovery), [scalingeurope.substack.com](https://scalingeurope.substack.com/p/scaling-europe-daily-2910), [pomegra.io](https://pomegra.io/startups/samplix-25m-first-close-led-by-wlan-2026-funding-explained-2026-10-30) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.